Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 216

1.

Familial pancreatic cancer risk: a population-based study in Utah.

Kohli DR, Smith KR, Wong J, Yu Z, Boucher K, Faigel DO, Pannala R, Burt RW, Curtin K, Samadder NJ.

J Gastroenterol. 2019 Jun 25. doi: 10.1007/s00535-019-01597-3. [Epub ahead of print]

PMID:
31240435
2.

Clinical and Molecular Features of Post-Colonoscopy Colorectal Cancers.

Samadder NJ, Neklason D, Snow A, Samowitz W, Cessna MH, Rowe K, Sandhu I, Boucher K, Pappas L, Smith KR, Wong J, Curtin K, Provenzale D, Burt RW.

Clin Gastroenterol Hepatol. 2019 Mar 29. pii: S1542-3565(19)30246-0. doi: 10.1016/j.cgh.2019.02.040. [Epub ahead of print]

PMID:
30930275
3.

Family History Associates With Increased Risk of Colorectal Cancer in Patients With Inflammatory Bowel Diseases.

Samadder NJ, Valentine JF, Guthery S, Singh H, Bernstein CN, Leighton JA, Wan Y, Wong J, Boucher K, Pappas L, Rowe K, Burt RW, Curtin K, Smith KR.

Clin Gastroenterol Hepatol. 2018 Sep 26. pii: S1542-3565(18)31029-2. doi: 10.1016/j.cgh.2018.09.038. [Epub ahead of print]

PMID:
30267862
4.

Small RNA sequencing of sessile serrated polyps identifies microRNA profile associated with colon cancer.

Kanth P, Hazel MW, Boucher KM, Yang Z, Wang L, Bronner MP, Boylan KE, Burt RW, Westover M, Neklason DW, Delker DA.

Genes Chromosomes Cancer. 2019 Jan;58(1):23-33. doi: 10.1002/gcc.22686. Epub 2018 Nov 18.

PMID:
30265426
5.

Variables affecting penetrance of gastric and duodenal phenotype in familial adenomatous polyposis patients.

Sample DC, Samadder NJ, Pappas LM, Boucher KM, Samowitz WS, Berry T, Westover M, Nathan D, Kanth P, Byrne KR, Burt RW, Neklason DW.

BMC Gastroenterol. 2018 Jul 16;18(1):115. doi: 10.1186/s12876-018-0841-8.

6.

Active BRAF-V600E is the key player in generation of a sessile serrated polyp-specific DNA methylation profile.

Dehghanizadeh S, Khoddami V, Mosbruger TL, Hammoud SS, Edes K, Berry TS, Done M, Samowitz WS, DiSario JA, Luba DG, Burt RW, Jones DA.

PLoS One. 2018 Mar 28;13(3):e0192499. doi: 10.1371/journal.pone.0192499. eCollection 2018.

7.

Association of Sulindac and Erlotinib vs Placebo With Colorectal Neoplasia in Familial Adenomatous Polyposis: Secondary Analysis of a Randomized Clinical Trial.

Samadder NJ, Kuwada SK, Boucher KM, Byrne K, Kanth P, Samowitz W, Jones D, Tavtigian SV, Westover M, Berry T, Jasperson K, Pappas L, Smith L, Sample D, Burt RW, Neklason DW.

JAMA Oncol. 2018 May 1;4(5):671-677. doi: 10.1001/jamaoncol.2017.5431.

8.

Anticoagulant Bridge Comparison in Mechanical Circulatory Support Patients.

Cosgrove RH, Basken RL, Smith RG, Hsu CH, Kazui T, Martinez BK, Burt RW, Crawford ES, Lick SD, Khalpey Z.

ASAIO J. 2019 Jan;65(1):54-58. doi: 10.1097/MAT.0000000000000747.

PMID:
29324514
9.

Chemoprevention with Cyclooxygenase and Epidermal Growth Factor Receptor Inhibitors in Familial Adenomatous Polyposis Patients: mRNA Signatures of Duodenal Neoplasia.

Delker DA, Wood AC, Snow AK, Samadder NJ, Samowitz WS, Affolter KE, Boucher KM, Pappas LM, Stijleman IJ, Kanth P, Byrne KR, Burt RW, Bernard PS, Neklason DW.

Cancer Prev Res (Phila). 2018 Jan;11(1):4-15. doi: 10.1158/1940-6207.CAPR-17-0130. Epub 2017 Nov 6.

10.

Developmental Delay and Colon Polyposis.

Samadder NJ, Burt RW, Toydemir RM.

Gastroenterology. 2017 Oct;153(4):908-909. doi: 10.1053/j.gastro.2017.03.056. Epub 2017 Sep 4. No abstract available.

PMID:
28881184
11.

Cancer Risk in Families Fulfilling the Amsterdam Criteria for Lynch Syndrome.

Samadder NJ, Smith KR, Wong J, Thomas A, Hanson H, Boucher K, Kopituch C, Cannon-Albright LA, Burt RW, Curtin K.

JAMA Oncol. 2017 Dec 1;3(12):1697-1701. doi: 10.1001/jamaoncol.2017.0769.

12.

Long-Term Colorectal Cancer Incidence After Negative Colonoscopy in the State of Utah: The Effect of Family History.

Samadder NJ, Pappas L, Boucherr KM, Smith KR, Hanson H, Fraser A, Wan Y, Burt RW, Curtin K.

Am J Gastroenterol. 2017 Sep;112(9):1439-1447. doi: 10.1038/ajg.2017.193. Epub 2017 Jul 11.

PMID:
28695908
13.

Reducing the polyp burden in serrated polyposis by serial colonoscopy: the impact of nationally coordinated community surveillance.

Parry S, Burt RW, Win AK, Aung YK, Woodall S, Arnold J, Clendenning M, Buchanan DD, Price TJ, Rosty C, Young JP.

N Z Med J. 2017 Mar 3;130(1451):57-67.

PMID:
28253245
14.

Colorectal Cancer in Inflammatory Bowel Diseases: A Population-Based Study in Utah.

Jewel Samadder N, Valentine JF, Guthery S, Singh H, Bernstein CN, Wan Y, Wong J, Boucher K, Pappas L, Rowe K, Bronner M, Ulrich CM, Burt RW, Curtin K, Smith KR.

Dig Dis Sci. 2017 Aug;62(8):2126-2132. doi: 10.1007/s10620-016-4435-4. Epub 2017 Jan 3.

PMID:
28050782
15.

A role for the vitamin D pathway in non-intestinal lesions in genetic and carcinogen models of colorectal cancer and in familial adenomatous polyposis.

Bong YS, Assefnia S, Tuohy T, Neklason DW, Burt RW, Ahn J, Bueno De Mesquita PJ, Byers SW.

Oncotarget. 2016 Dec 6;7(49):80508-80520. doi: 10.18632/oncotarget.12768.

16.

Gastrointestinal Polyposis in Cowden Syndrome.

Shaco-Levy R, Jasperson KW, Martin K, Samadder NJ, Burt RW, Ying J, Bronner MP.

J Clin Gastroenterol. 2017 Aug;51(7):e60-e67. doi: 10.1097/MCG.0000000000000703.

PMID:
27661969
17.

Familial Risk of Biliary Tract Cancers: A Population-Based Study in Utah.

Samadder NJ, Smith KR, Wong J, Hanson H, Boucher K, Burt RW, Charlton M, Byrne KR, Gallegos-Orozco JF, Koptiuch C, Curtin K.

Dig Dis Sci. 2016 Dec;61(12):3627-3632. Epub 2016 Sep 21.

PMID:
27655103
18.

Sulindac and Erlotinib for Familial Adenomatous Polyposis--Reply.

Samadder NJ, Neklason DW, Burt RW.

JAMA. 2016 Aug 2;316(5):545. doi: 10.1001/jama.2016.7595. No abstract available.

PMID:
27483082
19.

Understanding the contribution of family history to colorectal cancer risk and its clinical implications: A state-of-the-science review.

Lowery JT, Ahnen DJ, Schroy PC 3rd, Hampel H, Baxter N, Boland CR, Burt RW, Butterly L, Doerr M, Doroshenk M, Feero WG, Henrikson N, Ladabaum U, Lieberman D, McFarland EG, Peterson SK, Raymond M, Samadder NJ, Syngal S, Weber TK, Zauber AG, Smith R.

Cancer. 2016 Sep 1;122(17):2633-45. doi: 10.1002/cncr.30080. Epub 2016 Jun 3. Review. Erratum in: Cancer. 2017 Oct 1;123(19):3857.

20.

Gene Signature in Sessile Serrated Polyps Identifies Colon Cancer Subtype.

Kanth P, Bronner MP, Boucher KM, Burt RW, Neklason DW, Hagedorn CH, Delker DA.

Cancer Prev Res (Phila). 2016 Jun;9(6):456-65. doi: 10.1158/1940-6207.CAPR-15-0363. Epub 2016 Mar 29.

21.

Effect of Sulindac and Erlotinib vs Placebo on Duodenal Neoplasia in Familial Adenomatous Polyposis: A Randomized Clinical Trial.

Samadder NJ, Neklason DW, Boucher KM, Byrne KR, Kanth P, Samowitz W, Jones D, Tavtigian SV, Done MW, Berry T, Jasperson K, Pappas L, Smith L, Sample D, Davis R, Topham MK, Lynch P, Strait E, McKinnon W, Burt RW, Kuwada SK.

JAMA. 2016 Mar 22-29;315(12):1266-75. doi: 10.1001/jama.2016.2522.

22.

Familial Risk in Patients With Carcinoma of Unknown Primary.

Samadder NJ, Smith KR, Hanson H, Pimentel R, Wong J, Boucher K, Akerley W, Gilcrease G, Ulrich CM, Burt RW, Curtin K.

JAMA Oncol. 2016 Mar;2(3):340-6. doi: 10.1001/jamaoncol.2015.4265.

PMID:
26863281
23.

Morphologic characterization of hamartomatous gastrointestinal polyps in Cowden syndrome, Peutz-Jeghers syndrome, and juvenile polyposis syndrome.

Shaco-Levy R, Jasperson KW, Martin K, Samadder NJ, Burt RW, Ying J, Bronner MP.

Hum Pathol. 2016 Mar;49:39-48. doi: 10.1016/j.humpath.2015.10.002. Epub 2015 Oct 31.

PMID:
26826408
24.

Screening and Survival in Familial Adenomatous Polyposis.

Burt RW.

J Clin Gastroenterol. 2016 Jan;50(1):3-4. doi: 10.1097/MCG.0000000000000438. No abstract available.

25.

The Genetics of Colorectal Cancer.

Jasperson K, Burt RW.

Surg Oncol Clin N Am. 2015 Oct;24(4):683-703. doi: 10.1016/j.soc.2015.06.006. Epub 2015 Jul 15. Review.

PMID:
26363537
26.

Risk of Incident Colorectal Cancer and Death After Colonoscopy: A Population-based Study in Utah.

Samadder NJ, Curtin K, Pappas L, Boucher K, Mineau GP, Smith K, Fraser A, Wan Y, Provenzale D, Kinney AY, Ulrich C, Burt RW.

Clin Gastroenterol Hepatol. 2016 Feb;14(2):279-86.e1-2. doi: 10.1016/j.cgh.2015.08.033. Epub 2015 Sep 4.

PMID:
26343183
27.

Effectiveness of the extended parallel process model in promoting colorectal cancer screening.

Birmingham WC, Hung M, Boonyasiriwat W, Kohlmann W, Walters ST, Burt RW, Stroup AM, Edwards SL, Schwartz MD, Lowery JT, Hill DA, Wiggins CL, Higginbotham JC, Tang P, Hon SD, Franklin JD, Vernon S, Kinney AY.

Psychooncology. 2015 Oct;24(10):1265-1278. doi: 10.1002/pon.3899. Epub 2015 Jul 20.

PMID:
26194469
28.

Increased Risk of Colorectal Cancer Among Family Members of All Ages, Regardless of Age of Index Case at Diagnosis.

Samadder NJ, Smith KR, Hanson H, Pimentel R, Wong J, Boucher K, Ahnen D, Singh H, Ulrich CM, Burt RW, Curtin K.

Clin Gastroenterol Hepatol. 2015 Dec;13(13):2305-11.e1-2. doi: 10.1016/j.cgh.2015.06.040. Epub 2015 Jul 16.

PMID:
26188136
29.

Colonic polyps in lynch syndrome.

Burt RW.

Dis Colon Rectum. 2015 Apr;58(4):371-2. doi: 10.1097/DCR.0000000000000332. No abstract available.

PMID:
25751791
30.

ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes.

Syngal S, Brand RE, Church JM, Giardiello FM, Hampel HL, Burt RW; American College of Gastroenterology.

Am J Gastroenterol. 2015 Feb;110(2):223-62; quiz 263. doi: 10.1038/ajg.2014.435. Epub 2015 Feb 3. Review.

31.

Familial colorectal cancer risk by subsite of primary cancer: a population-based study in Utah.

Samadder NJ, Smith KR, Mineau GP, Pimentel R, Wong J, Boucher K, Pappas L, Singh H, Ahnen D, Burt RW, Curtin K.

Aliment Pharmacol Ther. 2015 Mar;41(6):573-80. doi: 10.1111/apt.13086. Epub 2015 Jan 21.

32.

Hereditary and common familial colorectal cancer: evidence for colorectal screening.

Samadder NJ, Jasperson K, Burt RW.

Dig Dis Sci. 2015 Mar;60(3):734-47. doi: 10.1007/s10620-014-3465-z. Epub 2014 Dec 12. Review.

PMID:
25501924
33.

APC promoter 1B deletion in seven American families with familial adenomatous polyposis.

Snow AK, Tuohy TM, Sargent NR, Smith LJ, Burt RW, Neklason DW.

Clin Genet. 2015 Oct;88(4):360-5. doi: 10.1111/cge.12503. Epub 2014 Oct 14.

34.

Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-society Task Force on colorectal cancer.

Giardiello FM, Allen JI, Axilbund JE, Boland CR, Burke CA, Burt RW, Church JM, Dominitz JA, Johnson DA, Kaltenbach T, Levin TR, Lieberman DA, Robertson DJ, Syngal S, Rex DK.

Am J Gastroenterol. 2014 Aug;109(8):1159-79. doi: 10.1038/ajg.2014.186. Epub 2014 Jul 22.

PMID:
25070057
35.

Systemic mastocytosis in a patient with Cowden syndrome.

Tantravahi SK, Schumacher J, Burt RW, Kelley TW, Deininger MW.

Am J Hematol. 2014 Dec;89(12):1154. doi: 10.1002/ajh.23815. Epub 2014 Aug 27. No abstract available.

36.

Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on colorectal cancer.

Giardiello FM, Allen JI, Axilbund JE, Boland CR, Burke CA, Burt RW, Church JM, Dominitz JA, Johnson DA, Kaltenbach T, Levin TR, Lieberman DA, Robertson DJ, Syngal S, Rex DK; US Multi-Society Task Force on Colorectal Cancer.

Gastroenterology. 2014 Aug;147(2):502-26. doi: 10.1053/j.gastro.2014.04.001. Review.

PMID:
25043945
37.

Increased risk of colorectal neoplasia among family members of patients with colorectal cancer: a population-based study in Utah.

Samadder NJ, Curtin K, Tuohy TM, Rowe KG, Mineau GP, Smith KR, Pimentel R, Wong J, Boucher K, Burt RW.

Gastroenterology. 2014 Oct;147(4):814-821.e5; quiz e15-6. doi: 10.1053/j.gastro.2014.07.006. Epub 2014 Jul 17.

PMID:
25042087
38.

Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the U.S. Multi-Society Task Force on Colorectal Cancer.

Giardiello FM, Allen JI, Axilbund JE, Boland CR, Burke CA, Burt RW, Church JM, Dominitz JA, Johnson DA, Kaltenbach T, Levin TR, Lieberman DA, Robertson DJ, Syngal S, Rex DK; American Society for Gastrointestinal Endoscopy.

Gastrointest Endosc. 2014 Aug;80(2):197-220. doi: 10.1016/j.gie.2014.06.006. Review. No abstract available.

PMID:
25034835
39.

Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on Colorectal Cancer.

Giardiello FM, Allen JI, Axilbund JE, Boland CR, Burke CA, Burt RW, Church JM, Dominitz JA, Johnson DA, Kaltenbach T, Levin TR, Lieberman DA, Robertson DJ, Syngal S, Rex DK.

Dis Colon Rectum. 2014 Aug;57(8):1025-48. doi: 10.1097/DCR.000000000000000.

PMID:
25003300
40.

Epidemiology and familial risk of synchronous and metachronous colorectal cancer: a population-based study in Utah.

Samadder NJ, Curtin K, Wong J, Tuohy TM, Mineau GP, Smith KR, Pimentel R, Pappas L, Boucher K, Garrido-Laguna I, Provenzale D, Burt RW.

Clin Gastroenterol Hepatol. 2014 Dec;12(12):2078-84.e1-2. doi: 10.1016/j.cgh.2014.04.017. Epub 2014 Apr 24.

PMID:
24768809
41.

RNA sequencing of sessile serrated colon polyps identifies differentially expressed genes and immunohistochemical markers.

Delker DA, McGettigan BM, Kanth P, Pop S, Neklason DW, Bronner MP, Burt RW, Hagedorn CH.

PLoS One. 2014 Feb 12;9(2):e88367. doi: 10.1371/journal.pone.0088367. eCollection 2014.

42.

Telehealth personalized cancer risk communication to motivate colonoscopy in relatives of patients with colorectal cancer: the family CARE Randomized controlled trial.

Kinney AY, Boonyasiriwat W, Walters ST, Pappas LM, Stroup AM, Schwartz MD, Edwards SL, Rogers A, Kohlmann WK, Boucher KM, Vernon SW, Simmons RG, Lowery JT, Flores K, Wiggins CL, Hill DA, Burt RW, Williams MS, Higginbotham JC.

J Clin Oncol. 2014 Mar 1;32(7):654-62. doi: 10.1200/JCO.2013.51.6765. Epub 2014 Jan 21.

43.

Characteristics of missed or interval colorectal cancer and patient survival: a population-based study.

Samadder NJ, Curtin K, Tuohy TM, Pappas L, Boucher K, Provenzale D, Rowe KG, Mineau GP, Smith K, Pimentel R, Kirchhoff AC, Burt RW.

Gastroenterology. 2014 Apr;146(4):950-60. doi: 10.1053/j.gastro.2014.01.013. Epub 2014 Jan 11.

PMID:
24417818
44.

Colorectal cancer screening.

Burt RW, Cannon JA, David DS, Early DS, Ford JM, Giardiello FM, Halverson AL, Hamilton SR, Hampel H, Ismail MK, Jasperson K, Klapman JB, Lazenby AJ, Lynch PM, Mayer RJ, Ness RM, Provenzale D, Rao MS, Shike M, Steinbach G, Terdiman JP, Weinberg D, Dwyer M, Freedman-Cass D; National comprehensive cancer network.

J Natl Compr Canc Netw. 2013 Dec 1;11(12):1538-75.

PMID:
24335688
45.

Colon cancer screening continues as pivotal to cancer prevention.

Burt RW.

J Natl Compr Canc Netw. 2013 Dec 1;11(12):1457-8. No abstract available.

PMID:
24335678
46.

Intention to undergo colonoscopy screening among relatives of colorectal cancer cases: a theory-based model.

Boonyasiriwat W, Hung M, Hon SD, Tang P, Pappas LM, Burt RW, Schwartz MD, Stroup AM, Kinney AY.

Ann Behav Med. 2014 Jun;47(3):280-91. doi: 10.1007/s12160-013-9562-y.

PMID:
24307472
47.

Risk of colorectal cancer and adenomas in the families of patients with adenomas: a population-based study in Utah.

Tuohy TM, Rowe KG, Mineau GP, Pimentel R, Burt RW, Samadder NJ.

Cancer. 2014 Jan 1;120(1):35-42. doi: 10.1002/cncr.28227. Epub 2013 Oct 21.

48.

Serrated polyposis: colonic phenotype, extracolonic features, and familial risk in a large cohort.

Jasperson KW, Kanth P, Kirchhoff AC, Huismann D, Gammon A, Kohlmann W, Burt RW, Samadder NJ.

Dis Colon Rectum. 2013 Nov;56(11):1211-6. doi: 10.1097/DCR.0b013e3182a11cca.

49.

Immunodepletion plasma proteomics by tripleTOF 5600 and Orbitrap elite/LTQ-Orbitrap Velos/Q exactive mass spectrometers.

Jones KA, Kim PD, Patel BB, Kelsen SG, Braverman A, Swinton DJ, Gafken PR, Jones LA, Lane WS, Neveu JM, Leung HE, Shaffer SA, Leszyk JD, Stanley BA, Fox TE, Stanley A, Hall MJ, Hampel H, South CD, de la Chapelle A, Burt RW, Jones DA, Kopelovich L, Yeung AT.

J Proteome Res. 2013 Oct 4;12(10):4351-65. doi: 10.1021/pr400307u. Epub 2013 Sep 19.

50.

Examining the challenges of family recruitment to behavioral intervention trials: factors associated with participation and enrollment in a multi-state colonoscopy intervention trial.

Simmons RG, Lee YC, Stroup AM, Edwards SL, Rogers A, Johnson C, Wiggins CL, Hill DA, Cress RD, Lowery J, Walters ST, Jasperson K, Higginbotham JC, Williams MS, Burt RW, Schwartz MD, Kinney AY.

Trials. 2013 Apr 30;14:116. doi: 10.1186/1745-6215-14-116.

Supplemental Content

Support Center